Ethanol → (R)-tert-butyl 2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H-benzo[d]imidazol-1-yl)methyl)morpholine-4-carboxylate

関与物質

反応手順

(R)-4-(1-((4-(tert-butoxycarbonyl)morpholin-2-yl)methyl)-5-methyl-1H-benzo[d]imidazol-2-yl)-3,5-difluorobenzoic acid (750 mg, 1.54 mmol) was added to DMT-MM (408 mg, 1.69 mmol) in DMF (30.00 mL) under N2. The resulting suspension was stirred for 30 min. Afterward, methylamine 33% (by weight) solution in absolute ethanol (0.458 mL, 1.69 mmol) was added, and the mixture was stirred for 3 hr. The mixture was then concentrated under reduced pressure, and the resulting residue was dissolved in EtOAc and washed sequentially with water and brine. The organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure. The crude material was purified on preparative HPLC MS using the short high pH shallow gradient method (mobile phase: 30-50% B; A: H2O with 10 mM NH4CO3 and 0.375% NH4OH v/v; B: CH3CN; 10 min run; XBridge Prep C18 OBD, Waters reverse phase column; column size: 30×50 mm; and particle size 5 μm). This produced (S)-tert-butyl 2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H-benzo[d]imidazol-1-yl)methyl)morpholine-4-carboxylate as an oil, which was used without further purification (1.4 g, >100% yield) in the next step. The oil was analyzed on analytical HPLC MS using the high pH gradient method (mobile phase: 5-95% B; A: H2O with 10 mM NH4CO3 and 0.375% NH4OH v/v; B: CH3CN; 2.25 min run; X-Bridge C18; column size: 2.1×30 mm, particle size: 5 μm). MS m/z 501.4 [M+H]+ (ESI), Rt 1.85 min.

情報源と証拠